| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: present invention refers to medicine, specifically cardiology, and concerns treating chronic cardiac failure. That is ensured by administering a pharmaceutical composition containing an activated potentiated form of very-low-dose angiotensin II receptor antibodies and an activated potentiated form of very-low-dose endothelial NO-synthase antibodies.EFFECT: method provides improving quality of life and higher tolerance to physical loads in the given group of patients.11 cl, 2 ex, 2 tbl |
